-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
- Aptose Biosciences Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $112K, a 2.61% decline year-over-year.
- Aptose Biosciences Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $458K, a 13.1% increase year-over-year.
- Aptose Biosciences Inc. annual Operating Lease, Payments for 2024 was $458K, a 13.1% increase from 2023.
- Aptose Biosciences Inc. annual Operating Lease, Payments for 2023 was $405K, a 25.8% decline from 2022.
- Aptose Biosciences Inc. annual Operating Lease, Payments for 2022 was $546K, a 1.62% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)